Skip to content
10-Q

Quarterly Report

PRECIGEN, INC. PGEN

0001356090-26-000017

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 356.51M sh
Shares Diluted Q1 2026 · Mar 31, 2026 354.29M sh
Shares Diluted Q1 2026 · Mar 31, 2025 293.88M sh
Capex Q1 2026 · Mar 31, 2026 $258K
Capex Q1 2026 · Mar 31, 2025 $622K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$43.83M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$16.33M
Long Term Debt Q1 2026 · Mar 31, 2026 $93.52M
Long Term Debt Q1 2026 · Dec 31, 2025 $93.17M
Short Term Investments Q1 2026 · Mar 31, 2026 $48.77M
Short Term Investments Q1 2026 · Dec 31, 2025 $67.62M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $7.48M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $30.23M
Stockholders Equity Q1 2026 · Mar 31, 2026 $20.24M
Stockholders Equity Q1 2026 · Dec 31, 2025 $20.91M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$14.06M
Stockholders Equity Q1 2026 · Dec 31, 2024 $38.51M
Current Liabilities Q1 2026 · Mar 31, 2026 $21.1M
Current Liabilities Q1 2026 · Dec 31, 2025 $37.31M
Total Liabilities Q1 2026 · Mar 31, 2026 $118.39M
Total Liabilities Q1 2026 · Dec 31, 2025 $134.59M
Current Assets Q1 2026 · Mar 31, 2026 $101.67M
Current Assets Q1 2026 · Dec 31, 2025 $115.24M
Total Assets Q1 2026 · Mar 31, 2026 $138.63M
Total Assets Q1 2026 · Dec 31, 2025 $155.51M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.02
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.18
Eps Basic Q1 2026 · Mar 31, 2026 −$0.02
Eps Basic Q1 2026 · Mar 31, 2025 −$0.18
Sga Expense Q1 2026 · Mar 31, 2026 $21.05M
Sga Expense Q1 2026 · Mar 31, 2025 $12.36M
Rd Expense Q1 2026 · Mar 31, 2026 $5.64M
Rd Expense Q1 2026 · Mar 31, 2025 $10.48M
Net Income Q1 2026 · Mar 31, 2026 −$7.93M
Net Income Q1 2026 · Mar 31, 2025 −$54.15M
Operating Income Q1 2026 · Mar 31, 2026 −$5.99M
Operating Income Q1 2026 · Mar 31, 2025 −$22.6M
Revenue Q1 2026 · Mar 31, 2026 $23.25M
Revenue Q1 2026 · Mar 31, 2025 $1.34M